Add Company
Join Now

Provectus Biopharmaceuticals Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Provectus Biopharmaceuticals's estimated annual revenue is currently $1.9M per year.(i)
  • Provectus Biopharmaceuticals's estimated revenue per employee is $232,500

Employee Data

  • Provectus Biopharmaceuticals has 8 Employees.(i)
  • Provectus Biopharmaceuticals grew their employee count by -20% last year.

Provectus Biopharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M1011%N/AN/A
#2
$5M3214%N/AN/A
#3
$3.6M2742%N/AN/A
#4
$1.1M7-22%N/AN/A
#5
$1.7M110%N/AN/A
#6
$0.8M40%N/AN/A
#7
$6M5469%N/AN/A
#8
$0.9M620%N/AN/A
#9
$4.8M264%N/AN/A
#10
$1.9M9-10%N/AN/A
Add Company

What Is Provectus Biopharmaceuticals?

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.9M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M814%N/A
#2
$0.6M8167%N/A
#3
$0.9M8-20%N/A
#4
$0.7M90%N/A
#5
$1.3M913%N/A